#RSV virus expected to add pressure on hospitals in many EU/EEA countries this season.
Thirteen EU/EEA Member States have reported a rise in RSV cases between October and 14 November 2022.
Full press release: https://www.ecdc.europa.eu/en/news-events/rsv-virus-expected-add-pressure-hospitals-many-eueea-countries-season
Respiratory syncytial virus (#RSV) is a seasonal virus that recurs throughout the year in Europe with peaks mainly during the autumn, winter, and spring months (October to April), and is a leading cause of acute lower respiratory tract infections in infants and young children.
Worldwide, the #RSV virus is estimated to cause 33 million cases and 66 000 to 199 000 deaths of children below five years every year.
In the EU, Norway and the United Kingdom, RSV causes an average of 213 000 annual hospitalisations in children under five years.
In addition, toddlers who have not encountered #RSV during the #COVID19 pandemic would be at an increased risk of infection.
Therapeutics against severe RSV infection have been approved, and researchers are in the process of developing vaccines.
🐦🔗: https://nitter.eu/ECDC_EU/status/1595439333762285569